期刊文献+

人源性抗核抗体Fab片段噬菌体抗体库的构建 被引量:2

Construction of human recombinant antinuclear antibody Fab library on the surface of phage
下载PDF
导出
摘要 目的构建人源性抗核抗体(ANA)Fab片段噬菌体抗体库。方法从4名ANA滴度大于1∶10000的自身免疫病患者外周血淋巴细胞中抽提总RNA,用RT-PCR技术扩增免疫球蛋白分子轻链κ、λ基因及重链Fd基因。将轻链基因片段克隆入pComb3Hss载体以构建轻链文库,随后将重链基因载入κ/λ-pComb3Hss载体,形成κ/λ-Fd-pComb3Hss质粒,然后将重组质粒转化大肠杆菌XL1-Blue。用辅助噬菌体M13KO7感染XL1-Blue,随机的重组抗体文库即表达于丝状噬菌体表面。结果扩增了长度为660bp的轻链κ、λ基因及重链Fd基因,并成功构建了库容为2×104的轻链基因抗体库和库容为4×104的人Fab抗体库,获得了噬菌体滴度为2×109CFU/ml的富含人源性抗核抗体Fab片段的噬菌体抗体库。结论成功构建了人源性抗核抗体Fab片段噬菌体抗体库,为人源性抗核抗体Fab片段的制备以及进一步评价其在肿瘤免疫靶向治疗中的作用奠定了基础。 Objective To construct a phage antibody Fab library of human antinuclear antibody. Methods Total RNA was extracted from peripheral blood lymphoeytes of 4 patients suffering from autoallergic disease, with antinuclear IgG antibody titers in the serum higher than 1:10 000 as estimated by indirect immunofluorescence technique. Taking oligo-dT as the primers, human immunoglobulin light chains κ/λgenes as well as heavy chains Fd genes were reversely transcribed to cDNA by PCIL The κ/λ light chains were initially cloned into pComb3Hss vector to construct a human recombinant light chain library, and the heavy chain genes were subsequently inserted into the corresponding sites of κ/λ-pComb3Hss plasmid to generate a recombinant κ/λ,-Fd-pComb3Hss plasmid. The plasmid was then transformed into E. coli XL1-Blue, which was subsequently infected by the helper phage M13KO7. A random recombinant antibody library was expressed on the surface of filamentous phage. Results Human immunoglobulin κ/λ, light chain and heavy chain Fd genes (660bp) were amplified successfully. The light chain library with the capacity size of 2 ×10^4 , and the human recombinant Fab antibody library with the ca- pacity size of 4 ×10^1 were also successfully obtained. Finally, the phage antibody library of the Fab fragment of human antinuclear antibody, containing 2×10^9 CFU/ml phage, was constructed. Conclusion A phage antibody library of Fab fragment of human antinuclear antibody is constructed successfully. This research lays a foundation for the preparation for phage library of Fab fragment of human antinuclear antibody, and also paves the way for the advanced assessment for its effect on the immuno-targeting therapy of tumors.
出处 《解放军医学杂志》 CAS CSCD 北大核心 2007年第11期1141-1144,共4页 Medical Journal of Chinese People's Liberation Army
基金 上海市科委科研计划项目(04DZ19106) 广东省科技计划项目(2005B10401022)
关键词 抗体 抗核 抗体 单克隆 噬菌体抗体库 肿瘤 antibodies, antinuclear antibodies, monoelonal phage antibody library neoplasm
  • 相关文献

参考文献15

  • 1Yu L,Ju DW,Chen W,et al.131I-chTNT radioimmunotherapy of 43 patients with advanced lung cancer.Cancer Biother Radiopharm,2006,21(1):5.
  • 2Liu A,Hu P,Khawli LA,et al.B7.1/NHS76:a new costimulator fusion protein for the immunotherapy of solid tumors.J Immunother,2006,29(4):425.
  • 3Mizokami MM,Hu P,Khawli LA,et al.Chimeric TNT-3 antibody/murine interferon-gamma fusion protein for the immunotherapy of solid malignancies.Hybrid Hybridomics,2003,22(4):197.
  • 4Biela BH,Khawli LA,Hu P,et al.Chimeric TNT-3/human beta-glucuronidase fusion proteins for antibody-directed enzyme prodrug therapy (ADEPT).Cancer Biother Radiopharm,2003,18(3):339.
  • 5Sharifi J,Khawli LA,Hu P,et al.Characterization of a phage display-derived human monoclonal antibody (NHS76) counterpart to chimeric TNT-1 directed against necrotic regions of solid tumors.Hybrid Hybridomics,2001,20(5-6):305.
  • 6Street HH,Goris ML,Fisher GA,et al.Phase I study of 131I-chimeric(ch) TNT-1/B monoclonal antibody for the treatment of advanced colon cancer.Cancer Biother Radiopharm,2006,21(3):243.
  • 7Shapiro WR,Carpenter SP,Roberts K,et al.(131)I-chTNT-1/B mAb:tumour necrosis therapy for malignant astrocytic glioma.Expert Opin Biol Ther,2006,6(5):539.
  • 8Khawli LA,Alauddin MM,Hu P,et al.Tumor targeting properties of indium-111 labeled genetically engineered Fab' and F(ab')2 constructs of chimeric tumor necrosis treatment (chTNT)-3 antibody.Cancer Biother Radiopharm,2003,18(6):931.
  • 9Velappan N,Martinez JS,Valero R,et al.Selection and characterization of scFv antibodies against the Sin Nombre hantavirus nucleocapsid protein.J Immunol Methods,2007,321(1-2):60.
  • 10Xia J,Bi H,Yao Q,et al.Construction of human ScFv phage display library against ovarian tumor.J Huazhong Univ Sci Technolog Med Sci,2006,26(5):497.

二级参考文献16

共引文献15

同被引文献12

  • 1张爱华,余模松.噬菌体抗体库技术[J].国际生物制品学杂志,2006,29(1):13-16. 被引量:6
  • 2Sharifi J, Khawli L A, H u P, King S, Epstein A L. Characterization of a phage display-derived human monoclonal antibody (NHS76) counterpart to chimeric TNT-1 directed against necrotic regions of solid tumors[J]. Hybrid Hybridomics, 2001,20 (5-6) :305-312.
  • 3Biela B H, Khawli L A, Hu P, Epstein A L. Chimeric TNT-3/human beta-glucuronidase fusion proteins for antibody-directed enzyme prodrug therapy (ADEPT)[J]. Cancer Biother Radiopharm,2003,18:339-353.
  • 4Mizokami M M, Hu P, Khawli L A, Epstein A L. Chimeric TNT-3 antibody/murine interferon-gamma fusion protein for the immunotherapy of solid malignancies[J]. Hybrid Hybridomics,2003,22 : 197-207.
  • 5Shapiro W R,Carpenter S P,Roberts K,Shan J S. ^131I-chTNT- 1/B mAb: tumour necrosis therapy for malignant astrocytic glioma[J]. Expert Opin Biol Ther, 2006,6 : 539-545.
  • 6Street H H,Goris M L,Fisher G A,Wessels B W,Cho C,Hernandez C,et al. Phase Ⅰ study of ^131I-chimeric(ch) TNT-1/B monoclonal antibody for the treatment of advanced colon cancer [J]. Cancer Biother Radiopharm, 2006,21 : 243-256.
  • 7Velappan N,Martinez J S,Valero R,Chasteen L,Ponce L,Bondu-Hawkins V,et al. Selection and characterization of scFv antibodies against the Sin Nombre hantavirus nucleocapsid protein[J]. J Immunol Methods, 2007,321 (1-2) : 60-69.
  • 8Xia J, Bi H,Yao Q, Qu S, Zong Y. Construction of human ScFv phage display library against ovarian tumor[J]. J Huazhong Univ Sci Technolog Med Sci, 2006,26: 497-499.
  • 9Schofield D J,Pope A R, Clementel V, Buckell J, Chapple S D, Clarke K F,et al. Application of phage display to high throughput antibody generation and characterization[J]. Genome Biol, 2007,8: R254.
  • 10Eisenhardt S U, Schwarz M, Bassler N, Peter K. Subtractive single-chain antibody (scFv) phage-display:tailoring phage-display for high specificity against function-specific conformations of cell membrane molecules [J]. Nat Protoc, 2007,2: 3063- 3073.

引证文献2

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部